Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model ; volume:5 ; number:6 ; day:27 ; month:11 ; year:2013 ; pages:1-12 ; date:12.2013
Alzheimer's research & therapy ; 5, Heft 6 (27.11.2013), 1-12, 12.2013

Creator
Meister, Sabrina
Contributor
Zlatev, Iavor
Stab, Julia
Docter, Dominic
Baches, Sandra
Stauber, Roland H.
Deutsch, Mordechai
Schmidt, Reinhold
Ropele, Stefan
Windisch, Manfred
Langer, Klaus
Wagner, Sylvia
von Briesen, Hagen
Weggen, Sascha
Pietrzik, Claus U.
SpringerLink (Online service)

DOI
10.1186/alzrt225
URN
urn:nbn:de:1111-2016073131607
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Meister, Sabrina
  • Zlatev, Iavor
  • Stab, Julia
  • Docter, Dominic
  • Baches, Sandra
  • Stauber, Roland H.
  • Deutsch, Mordechai
  • Schmidt, Reinhold
  • Ropele, Stefan
  • Windisch, Manfred
  • Langer, Klaus
  • Wagner, Sylvia
  • von Briesen, Hagen
  • Weggen, Sascha
  • Pietrzik, Claus U.
  • SpringerLink (Online service)

Other Objects (12)

Nanoparticulate transport of oximes over an in vitro blood-brain barrier model

Nanoparticulate transport of oximes over an in vitro blood-brain barrier model

Photostimulation of Extravasation of Beta-Amyloid through the Model of Blood-Brain Barrier

Photostimulation of Extravasation of Beta-Amyloid through the Model of Blood-Brain Barrier

iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta

miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6

miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6

miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6

miR-29c-5p knockdown reduces inflammation and blood–brain barrier disruption by upregulating LRP6

Modulation of the blood-brain barrier

Hochschulschrift

Modulation of the blood-brain barrier

Modulation of the blood-brain barrier

Hochschulschrift

Modulation of the blood-brain barrier

Epigenetics in blood–brain barrier disruption

Epigenetics in blood–brain barrier disruption

Consequences of blood-brain barrier disruption

Hochschulschrift

Consequences of blood-brain barrier disruption

Mucopolysaccharidoses and the blood–brain barrier

Mucopolysaccharidoses and the blood–brain barrier

Breaking barriers: noncanonical inflammasome executes blood–brain barrier disruption

Breaking barriers: noncanonical inflammasome executes blood–brain barrier disruption

The contribution of β-amyloid, Tau and α-synuclein to blood–brain barrier damage in neurodegenerative disorders

The contribution of β-amyloid, Tau and α-synuclein to blood–brain barrier damage in neurodegenerative disorders

Related objects